Biological
TCR-T cells
TCR-T cells is a biological therapy with 5 clinical trials. Currently 1 active trials ongoing.
Total Trials
5
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Active Trials
1(20%)
Phase Distribution
Ph phase_1
3
60%
Ph early_phase_1
2
40%
Phase Distribution
5
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
2(40.0%)
Phase 1Safety & dosage
3(60.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(4)
Other(1)
Detailed Status
Not yet recruiting3
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
N/A
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 12 (40.0%)
Phase 13 (60.0%)
Trials by Status
unknown120%
not_yet_recruiting360%
recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
not_yet_recruitingearly_phase_1
TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors
NCT07342738
not_yet_recruitingphase_1
A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors
NCT07014878
recruitingphase_1
TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors
NCT03778814
not_yet_recruitingearly_phase_1
TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors
NCT05648994
unknownphase_1
TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation
NCT04677088
Clinical Trials (5)
Showing 5 of 5 trials
NCT07342738Early Phase 1
TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors
NCT07014878Phase 1
A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors
NCT03778814Phase 1
TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors
NCT05648994Early Phase 1
TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors
NCT04677088Phase 1
TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5